Preparing your page
We are fetching the latest content for you.
Specialized Healthcare Division of Al Ahlam Group
Company Overview
Damira Pharma was founded in 2025 as the specialized healthcare division of Al Ahlam Group, established in 1974.
The group is ISO and FDA certified and supports nationwide execution through trusted infrastructure and disciplined governance.
A long-term strategy anchored in access, quality, and scientific commercialization.
To be the preferred strategic partner for global healthcare innovators seeking resilient and compliant growth in Syria.
Every process is designed for consistency, documentation, and patient safety.
50+ Years
+20%
Nationwide
To provide a GDP-compliant ecosystem that ensures safe and reliable access to therapies while building sustainable partnerships.
Clinical accuracy and evidence-based engagement guide all field and medical activities.
Transparent collaboration with principled governance and long-term accountability.
Structured capability-building programs sustain performance and leadership continuity.
Operational decisions prioritize therapeutic access and continuity of care.
Long-term
A specialized healthcare platform strengthened by mature regional execution.
Damira benefits from established healthcare relationships and a national network shaped through decades of operational execution.
The organization combines mature governance with agile market operations to scale partners sustainably.